What is Galium verum used for traditionally?

Galium verum, commonly called lady's bedstraw, has been traditionally used in European herbal medicine as a diuretic, to support urinary tract health, and topically for skin conditions including eczema and psoriasis. The EMA monograph recognizes this traditional use based on at least 30 years of documented application, though it does not constitute approval for specific therapeutic claims.

Does Galium verum help with psoriasis?

Preliminary animal research showed that Galium verum extract reduced PASI scores and epidermal thickness by approximately 32% in rat psoriasis models, alongside significant increases in antioxidant enzymes SOD and CAT. However, these findings have not yet been replicated in human clinical trials, so evidence remains insufficient to recommend it as a standalone psoriasis treatment.

What are the active compounds in Galium verum?

The primary bioactive constituents of Galium verum include flavonoids such as luteolin and quercetin, iridoid glycosides including asperuloside, tannins, anthraquinones like alizarin and purpurin, and organic acids. Luteolin and quercetin are considered the main drivers of its antioxidant and anti-inflammatory pharmacological activity via NF-κB and Nrf2 pathway modulation.

Are there any drug interactions with Galium verum?

Galium verum may theoretically interact with anticoagulant or antiplatelet drugs such as warfarin or aspirin, as its quercetin content can influence platelet aggregation and cytochrome P450 enzyme activity. Its diuretic properties may also potentiate the effects of prescription diuretics such as furosemide, potentially increasing the risk of electrolyte imbalance. Patients on these medications should consult a healthcare provider before use.

What dose of Galium verum is typically used?

No standardized clinical dosing protocol has been established for Galium verum due to the absence of human pharmacokinetic studies. Traditional herbal preparations typically involve 2–4 grams of dried herb as an infusion taken two to three times daily, or equivalent liquid extract doses. Dose recommendations in the EMA monograph are based on traditional use patterns rather than clinical dose-finding trials.

What does clinical research show about Galium verum's effectiveness for psoriasis?

Animal studies demonstrate that Galium verum reduces PASI scores and epidermal thickness by approximately 32% in psoriatic models, with antioxidant mechanisms including increased glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) levels. However, clinical evidence in humans remains limited, and most published data comes from preclinical research in rat models rather than controlled human trials. Additional well-designed clinical studies are needed to confirm efficacy and establish therapeutic relevance in human psoriasis management.

Can Galium verum help protect the heart in people with psoriasis?

Preliminary evidence from animal studies suggests Galium verum may reduce cardiac oxidative stress and collagen accumulation in psoriasis-related heart damage, indicating potential cardiovascular protective effects. This is relevant because psoriasis is associated with increased cardiovascular complications due to systemic inflammation. However, these findings are from laboratory research and have not yet been confirmed in human clinical trials, so cardiovascular benefits cannot be claimed without further evidence.

Who should avoid taking Galium verum or use it with caution?

Safety data is limited, particularly for pregnant and breastfeeding women, children, and those with severe liver or kidney disease, who should consult a healthcare provider before use. Individuals taking medications metabolized by the liver or those on anticoagulants should exercise caution due to potential interaction risks. As Galium verum is classified under WHO/EMA monograph plants, quality and standardization vary by product, making medical supervision advisable for vulnerable populations.

Galium verum

Galium verum (lady's bedstraw) contains bioactive flavonoids including luteolin and quercetin, alongside iridoids and tannins, which drive its primary antioxidant and anti-inflammatory mechanisms. These compounds modulate oxidative stress pathways by upregulating endogenous antioxidant enzymes such as superoxide dismutase (SOD) and catalase (CAT), making it relevant to skin and cardiovascular research.

Category: European Evidence: 2/10 Tier: Emerging

Origin & History

Galium verum, commonly known as Lady's Bedstraw, is a herbaceous perennial plant of the Rubiaceae family, native to Europe and Asia. The aerial parts are harvested and processed into extracts, typically prepared as aqueous decoctions, ethanolic extracts, or diethyl ether/butanol fractions, yielding polyphenol-rich preparations high in flavonoids like rutin.

Historical & Cultural Context

In European traditional medicine, Galium verum has been used for centuries as internal and external decoctions for diuretic, anti-inflammatory, antimicrobial, analgesic, and anticancer properties. Historical applications for wound healing and infection treatment align with modern antimicrobial and cytotoxic findings.

Health Benefits

• Psoriasis management: Reduced PASI scores and epidermal thickness by 32% in rat models (preliminary evidence)
• Antioxidant protection: Increased GSH, SOD, and CAT levels while reducing lipid peroxidation in psoriatic tissue (animal studies)
• Cardiovascular protection: Reduced cardiac oxidative stress and collagen content in psoriasis-related heart damage (preliminary evidence, PMID: 39894905)
• Anti-cancer properties: Inhibited growth and motility of drug-resistant laryngeal carcinoma cells in vitro (cell studies only)
• Anti-inflammatory effects: Demonstrated reduction in inflammatory biomarkers including nitrites in animal psoriasis models

How It Works

Galium verum's flavonoids, particularly luteolin and quercetin, inhibit NF-κB signaling and suppress pro-inflammatory cytokine production including TNF-α and IL-6, reducing epidermal hyperproliferation in inflammatory skin conditions. These same compounds upregulate Nrf2-mediated antioxidant response, increasing glutathione (GSH) synthesis and the activity of SOD and CAT, thereby reducing lipid peroxidation measured by malondialdehyde (MDA) levels. Iridoid glycosides present in the plant may contribute additional hepatoprotective and diuretic effects through modulation of COX-2 enzyme activity.

Scientific Research

Evidence for Galium verum is limited to preclinical studies with no human clinical trials identified. Key animal studies include imiquimod-induced psoriasis models in Wistar rats showing reduced epidermal thickness and oxidative stress markers, and in vitro studies demonstrating antiproliferative effects on cancer cell lines (PMID: 39894905, 38255727).

Clinical Summary

Current evidence for Galium verum is predominantly preclinical; a rat model of psoriasis demonstrated a 32% reduction in PASI scores and epidermal thickness alongside measurable increases in GSH, SOD, and CAT levels in psoriatic tissue. Animal studies have also documented reduced cardiac oxidative stress markers, suggesting cardiovascular protective potential, though no large-scale human randomized controlled trials have been published to date. The European Medicines Agency (EMA) has issued a monograph recognizing its traditional use, which is based on historical application rather than robust clinical trial data. Overall, evidence strength is low-to-moderate and primarily mechanistic; human dose-response data are currently lacking.

Nutritional Profile

Galium verum (Lady's Bedstraw) is a herbaceous plant with limited systematic nutritional analysis, but several bioactive constituents have been characterized. Bioactive compounds: Iridoids including asperuloside (0.05–0.3% dry weight), which undergoes hydrolysis to produce bioactive aglycones with anti-inflammatory properties. Flavonoids present at approximately 0.5–1.2% dry weight, including luteolin, quercetin, and rutin — quercetin content estimated at 0.1–0.4% in aerial parts. Anthraquinones (primarily in roots): alizarin, purpurin, and pseudopurpurin at trace to 0.1% levels; aerial parts contain minimal anthraquinones. Tannins: gallotannins and ellagitannins estimated at 2–5% dry weight, contributing to astringent properties. Coumarins: umbelliferone and scopoletin at trace levels (<0.05%). Organic acids: citric acid and tartaric acid present in moderate concentrations. Chlorogenic acid and caffeic acid derivatives reported in aerial parts. Volatile oils: trace amounts (<0.1%) including linalool and geraniol. Polysaccharides: structural carbohydrates comprising the majority of dry mass (~40–60%). Protein content: modest at approximately 8–12% dry weight in aerial parts. Fiber: significant insoluble fiber component (~20–30% dry weight). Minerals: calcium and potassium are the predominant minerals; iron and magnesium present at moderate levels; no precise mg/g quantification established in peer-reviewed literature. Vitamins: Vitamin C reported in fresh plant material at low concentrations; specific quantification limited. Chlorophyll pigments present in aerial parts. Bioavailability notes: Iridoid glycosides require gut microbiota-mediated hydrolysis for activation; flavonoid bioavailability is moderate and enhanced by quercetin's aglycone form; tannins may reduce mineral absorption when consumed in large quantities; anthraquinone content in aerial parts is insufficient for laxative effect. Most nutritional data derives from phytochemical screening studies rather than controlled nutritional analysis.

Preparation & Dosage

No clinically studied human dosages are available. Preclinical studies used oral administration in rats without specified mg/kg equivalents, and in vitro studies used ethanolic extracts at 55-200 µg/mL on cell cultures. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Green tea extract, Quercetin, Milk thistle, Alpha-lipoic acid

Safety & Interactions

Galium verum has a long history of traditional use and is generally considered well-tolerated at typical herbal doses, with no severe adverse effects documented in available literature. Due to its tannin content, gastrointestinal discomfort such as nausea or constipation may occur with high doses or prolonged use. Theoretical interactions exist with anticoagulant medications such as warfarin due to flavonoid-mediated effects on platelet aggregation, and caution is warranted when combining with diuretic drugs given the plant's known diuretic properties. Safety data for use during pregnancy and lactation are insufficient, and use in these populations is not recommended per the EMA monograph guidance.